NCT07088913 2026-03-03
A Study to Investigate the Effect of Capivasertib on the Pharmacokinetics of Oral Rosuvastatin in Healthy Participants
AstraZeneca
Phase 1 Completed
AstraZeneca
AstraZeneca
Genentech, Inc.
AstraZeneca
Amgen
Alexion Pharmaceuticals, Inc.
Janssen Research & Development, LLC